{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:47:24Z","timestamp":1783828044239,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T00:00:00Z","timestamp":1428710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00380-015-0677-x","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T23:31:28Z","timestamp":1428708688000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Safety and efficacy of sustained release of basic fibroblast growth factor using gelatin hydrogel in patients with critical limb ischemia"],"prefix":"10.1007","volume":"31","author":[{"given":"Motoyuki","family":"Kumagai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Marui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Yanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiko","family":"Ito-Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yokode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,11]]},"reference":[{"key":"677_CR1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:S5\u201356","journal-title":"J Vasc Surg"},{"key":"677_CR2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00380-013-0334-1","volume":"29","author":"M Takahara","year":"2014","unstructured":"Takahara M, Kaneto H, Katakami N, Iida O, Matsuoka T, Shimomura I (2014) Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia. Heart Vessels 29:563\u2013567","journal-title":"Heart Vessels"},{"key":"677_CR3","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1253\/circj.CJ-11-0103","volume":"75","author":"BP Yan","year":"2011","unstructured":"Yan BP, Moran D, Hynes BG, Kiernan TJ, Yu CM (2011) Advances in endovascular treatment of critical limb ischemia. Circ J 75:756\u2013765","journal-title":"Circ J"},{"key":"677_CR4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/73673","volume":"18","author":"J Grisham","year":"2000","unstructured":"Grisham J (2000) Inquiry into gene therapy widens. Nat Biotechnol 18:254\u2013255","journal-title":"Nat Biotechnol"},{"key":"677_CR5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427\u2013435","journal-title":"Lancet"},{"key":"677_CR6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/249123a0","volume":"249","author":"D Gospodarowicz","year":"1974","unstructured":"Gospodarowicz D (1974) Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249:123\u2013127","journal-title":"Nature"},{"key":"677_CR7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/edrv-8-2-95","volume":"8","author":"D Gospodarowicz","year":"1987","unstructured":"Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G (1987) Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95\u2013114","journal-title":"Endocr Rev"},{"key":"677_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0169-409X(97)00125-7","volume":"31","author":"Y Ikada","year":"1998","unstructured":"Ikada Y, Tabata Y (1998) Protein release from gelatin matrices. Adv Drug Deliv Rev 31:287\u2013301","journal-title":"Adv Drug Deliv Rev"},{"key":"677_CR9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0168-3659(03)00197-4","volume":"90","author":"T Kushibiki","year":"2003","unstructured":"Kushibiki T, Tomoshige R, Fukunaka Y, Kakemi M, Tabata Y (2003) In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Control Release 90:207\u2013216","journal-title":"J Control Release"},{"key":"677_CR10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1253\/circj.CJ-07-0960","volume":"72","author":"Y Huang","year":"2008","unstructured":"Huang Y, Marui A, Sakaguchi H, Esaki J, Arai Y, Hirose K, Bir SC, Horiuchi H, Maruyama T, Ikeda T, Tabata Y, Komeda M (2008) Sustained release of prostaglandin E1 potentiates the impaired therapeutic angiogenesis by basic fibroblast growth factor in diabetic murine hindlimb ischemia. Circ J 72:1693\u20131699","journal-title":"Circ J"},{"key":"677_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1253\/circj.72.633","volume":"72","author":"SC Bir","year":"2008","unstructured":"Bir SC, Fujita M, Marui A, Hirose K, Arai Y, Sakaguchi H, Huang Y, Esaki J, Ikeda T, Tabata Y, Komeda M (2008) New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. Circ J 72:633\u2013640","journal-title":"Circ J"},{"key":"677_CR12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00380-006-0967-4","volume":"22","author":"K Hirose","year":"2007","unstructured":"Hirose K, Marui A, Arai Y, Nomura T, Kaneda K, Kimura Y, Ikeda T, Fujita M, Mitsuyama M, Tabata Y, Komeda M (2007) A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice. Heart Vessels 22:261\u2013267","journal-title":"Heart Vessels"},{"key":"677_CR13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00380-006-0934-0","volume":"22","author":"K Doi","year":"2007","unstructured":"Doi K, Ikeda T, Marui A, Kushibiki T, Arai Y, Hirose K, Soga Y, Iwakura A, Ueyama K, Yamahara K, Itoh H, Nishimura K, Tabata Y, Komeda M (2007) Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia. Heart Vessels 22:104\u2013108","journal-title":"Heart Vessels"},{"key":"677_CR14","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1253\/circj.71.412","volume":"71","author":"Y Arai","year":"2007","unstructured":"Arai Y, Fujita M, Marui A, Hirose K, Sakaguchi H, Ikeda T, Tabata Y, Komeda M (2007) Combined treatment with sustained-release basic fibroblast growth factor and heparin enhances neovascularization in hypercholesterolemic mouse hindlimb ischemia. Circ J 71:412\u2013417","journal-title":"Circ J"},{"key":"677_CR15","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1253\/circj.70.1190","volume":"70","author":"K Hirose","year":"2006","unstructured":"Hirose K, Fujita M, Marui A, Arai Y, Sakaguchi H, Huang Y, Chandra S, Tabata Y, Komeda M (2006) Combined treatment of sustained-release basic fibroblast growth factor and sarpogrelate enhances collateral blood flow effectively in rabbit hindlimb ischemia. Circ J 70:1190\u20131194","journal-title":"Circ J"},{"key":"677_CR16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jvs.2004.10.029","volume":"41","author":"A Marui","year":"2005","unstructured":"Marui A, Kanematsu A, Yamahara K, Doi K, Kushibiki T, Yamamoto M, Itoh H, Ikeda T, Tabata Y, Komeda M (2005) Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation. J Vasc Surg 41:82\u201390","journal-title":"J Vasc Surg"},{"key":"677_CR17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10047-004-0252-1","volume":"7","author":"H Nakajima","year":"2004","unstructured":"Nakajima H, Sakakibara Y, Tambara K, Iwakura A, Doi K, Marui A, Ueyama K, Ikeda T, Tabata Y, Komeda M (2004) Therapeutic angiogenesis by the controlled release of basic fibroblast growth factor for ischemic limb and heart injury: toward safety and minimal invasiveness. J Artif Organs 7:58\u201361","journal-title":"J Artif Organs"},{"key":"677_CR18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-5223(03)00025-4","volume":"126","author":"A Iwakura","year":"2003","unstructured":"Iwakura A, Tabata Y, Koyama T, Doi K, Nishimura K, Kataoka K, Fujita M, Komeda M (2003) Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries. J Thorac Cardiovasc Surg 126:1113\u20131120","journal-title":"J Thorac Cardiovasc Surg"},{"key":"677_CR19","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1253\/circj.71.1181","volume":"71","author":"A Marui","year":"2007","unstructured":"Marui A, Tabata Y, Kojima S, Yamamoto M, Tambara K, Nishina T, Saji Y, Inui K, Hashida T, Yokoyama S, Onodera R, Ikeda T, Fukushima M, Komeda M (2007) A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I\u2013IIa study. Circ J 71:1181\u20131186","journal-title":"Circ J"},{"key":"677_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0168-3659(94)00035-2","volume":"31","author":"Y Tabata","year":"1994","unstructured":"Tabata Y, Hijikata S, Ikada Y (1994) Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release 31:189\u2013199","journal-title":"J Control Release"},{"key":"677_CR21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1163\/156856299X00298","volume":"10","author":"Y Tabata","year":"1999","unstructured":"Tabata Y, Hijikata S, Muniruzzaman M, Ikada Y (1999) Neovascularization effect of biodegradable gelatin microspheres incorporating basic fibroblast growth factor. J Biomater Sci Polym Ed 10:79\u201394","journal-title":"J Biomater Sci Polym Ed"},{"key":"677_CR22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1532-5415.1998.tb03804.x","volume":"46","author":"PS Montgomery","year":"1998","unstructured":"Montgomery PS, Gardner AW (1998) The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc 46:706\u2013711","journal-title":"J Am Geriatr Soc"},{"key":"677_CR23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN (1997) Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26:517\u2013538","journal-title":"J Vasc Surg"},{"key":"677_CR24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF02001886","volume":"10","author":"TJ Bunt","year":"1996","unstructured":"Bunt TJ, Holloway GA (1996) TcPO2 as an accurate predictor of therapy in limb salvage. Ann Vasc Surg 10:224\u2013227","journal-title":"Ann Vasc Surg"},{"key":"677_CR25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.med.56.082103.104649","volume":"56","author":"I Baumgartner","year":"2005","unstructured":"Baumgartner I, Schainfeld R, Graziani L (2005) Management of peripheral vascular disease. Annu Rev Med 56:249\u2013272","journal-title":"Annu Rev Med"},{"key":"677_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jvs.2006.03.026","volume":"44","author":"WA Marston","year":"2006","unstructured":"Marston WA, Davies SW, Armstrong B, Farber MA, Mendes RC, Fulton JJ, Keagy BA (2006) Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 44:108\u2013114","journal-title":"J Vasc Surg"},{"key":"677_CR27","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00380-012-0244-7","volume":"28","author":"P Yang","year":"2013","unstructured":"Yang P, Guo T, Wang W, Peng YZ, Wang Y, Zhou P, Luo ZL, Cai HY, Zhao L, Yang HW (2013) Randomized and double-blind controlled clinicaltrial of extracorporeal cardiac shock wave therapy for coronary heart disease. Heart Vessels 28:284\u2013291","journal-title":"Heart Vessels"},{"key":"677_CR28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11748-012-0153-9","volume":"61","author":"Y Sawa","year":"2013","unstructured":"Sawa Y (2013) Current status of myocardial regeneration therapy. Gen Thorac Cardiovasc Surg 61:17\u201323","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"677_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","volume":"118","author":"RJ Powell","year":"2008","unstructured":"Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M, Morishita R, Annex BH (2008) Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118:58\u201365","journal-title":"Circulation"},{"key":"677_CR30","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/gt.2010.51","volume":"17","author":"H Shigematsu","year":"2010","unstructured":"Shigematsu H, Yasuda K, Iwai T, Sasajima T, Ishimaru S, Ohashi Y, Yamaguchi T, Ogihara T, Morishita R (2010) Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther 17:1152\u20131161","journal-title":"Gene Ther"},{"key":"677_CR31","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","volume":"377","author":"J Belch","year":"2011","unstructured":"Belch J, Hiatt WR, Baumgartner I, Driver IV, Nikol S, Norgren L, Van Bell E (2011) Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia. Lancet 377:1929\u20131937","journal-title":"Lancet"},{"key":"677_CR32","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1253\/circj.CJ-11-1135","volume":"76","author":"HC Lee","year":"2012","unstructured":"Lee HC, An SG, Lee HW, Park JS, Cha KS, Hong TJ, Park JH, Lee SY, Kim SP, Kim YD, Chung SW, Bae YC, Shin YB, Kim JI, Jung JS (2012) Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J 76:1750\u20131760","journal-title":"Circ J"},{"key":"677_CR33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/13467","volume":"5","author":"SY Chan","year":"1999","unstructured":"Chan SY, Li K, Piccotti JR, Louie MC, Judge TA, Turka LA, Eichwald EJ, Bishop DK (1999) Tissue-specific consequences of the anti-adenoviral immune response: implications for cardiac transplants. Nat Med 5:1143\u20131149","journal-title":"Nat Med"},{"key":"677_CR34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bjs.7743","volume":"99","author":"NA Mughal","year":"2012","unstructured":"Mughal NA, Russell DA, Ponnambalam S, Homer-Vanniasinkam S (2012) Gene therapy in the treatment of peripheral arterial disease. Br J Surg 99:6\u201315","journal-title":"Br J Surg"},{"key":"677_CR35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0741-5214(92)90106-I","volume":"16","author":"R Baffour","year":"1992","unstructured":"Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16:181\u2013191","journal-title":"J Vasc Surg"},{"key":"677_CR36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2741\/s12","volume":"1","author":"F Strutz","year":"2009","unstructured":"Strutz F (2009) The role of FGF-2 in renal fibrogenesis. Front Biosci 1:125\u2013131","journal-title":"Front Biosci"},{"key":"677_CR37","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ten.1999.5.127","volume":"5","author":"Y Tabata","year":"1999","unstructured":"Tabata Y, Nagano A, Ikada Y (1999) Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5:127\u2013138","journal-title":"Tissue Eng"},{"key":"677_CR38","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0142-9612(99)00121-0","volume":"20","author":"Y Tabata","year":"1999","unstructured":"Tabata Y, Ikada Y (1999) Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20:2169\u20132175","journal-title":"Biomaterials"},{"key":"677_CR39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","volume":"209","author":"GP Fadini","year":"2010","unstructured":"Fadini GP, Agostini C, Avogaro A (2010) Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis 209:10\u201317","journal-title":"Atherosclerosis"},{"key":"677_CR40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCINTERVENTIONS.110.955724","volume":"4","author":"N Idei","year":"2011","unstructured":"Idei N, Soga J, Hata T, Fujii Y, Fujimura N, Mikami S, Maruhashi T, Nishioka K, Hidaka T, Kihara Y, Chowdhury M, Noma K, Taguchi A, Chayama K, Sueda T, Higashi Y (2011) Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv 4:15\u201325","journal-title":"Circ Cardiovasc Interv"},{"key":"677_CR41","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ahj.2008.06.025","volume":"156","author":"S Matoba","year":"2008","unstructured":"Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H (2008) Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (therapeutic angiogenesis by cell transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J 156:1010\u20131018","journal-title":"Am Heart J"},{"key":"677_CR42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.ackd.2008.07.008","volume":"15","author":"IP Casserly","year":"2008","unstructured":"Casserly IP (2008) Interventional management of critical limb ischemia in renal patients. Adv Chronic Kidney Dis 15:384\u2013395","journal-title":"Adv Chronic Kidney Dis"},{"key":"677_CR43","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1067\/mva.2002.123677","volume":"35","author":"AJ Comerota","year":"2002","unstructured":"Comerota AJ, Throm RC, Miller KA, Henry T, Chronos N, Laird J, Sequeira R, Kent CK, Bacchetta M, Goldman C, Salenius JP, Schmieder FA, Pilsudski R (2002) Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg 35:930\u2013936","journal-title":"J Vasc Surg"},{"key":"677_CR44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000136394.08900.ed","volume":"44","author":"R Morishita","year":"2004","unstructured":"Morishita R, Aoki M, Hashiya N, Makino H, Yamasaki K, Azuma J, Sawa Y, Matsuda H, Kaneda Y, Ogihara T (2004) Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44:203\u2013209","journal-title":"Hypertension"},{"key":"677_CR45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jvs.2013.01.037","volume":"58","author":"Z Dong","year":"2013","unstructured":"Dong Z, Chen B, Fu W, Wang Y, Guo D, Wei Z, Xu X, Mendelsohn FO (2013) Transplantation of purified CD34+ cells in the treatment of critical limb ischemia. J Vasc Surg 58:404\u2013411","journal-title":"J Vasc Surg"},{"key":"677_CR46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2012.07.031","volume":"224","author":"M Kinoshita","year":"2012","unstructured":"Kinoshita M, Fujita Y, Katayama M, Baba R, Shibakawa M, Yoshikawa K, Katakami N, Furukawa Y, Tsukie T, Nagano T, Kurimoto Y, Yamasaki K, Handa N, Okada Y, Kuronaka K, Nagata Y, Matsubara Y, Fukushima M, Asahara T, Kawamoto A (2012) Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. Atherosclerosis 224:440\u2013445","journal-title":"Atherosclerosis"},{"key":"677_CR47","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jvs.2011.01.074","volume":"53","author":"MP Murphy","year":"2011","unstructured":"Murphy MP, Lawson JH, Rapp BM, Dalsing MC, Klein J, Wilson MG, Hutchins GD, March KL (2011) Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg 53:1565\u20131574","journal-title":"J Vasc Surg"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-015-0677-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-015-0677-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-015-0677-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:27:50Z","timestamp":1559057270000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-015-0677-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,11]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["677"],"URL":"https:\/\/doi.org\/10.1007\/s00380-015-0677-x","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,11]]}}}